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Abstract 
Lung surfactants [LS] are a complex mixture of lipids and proteins that line the air-water interface 
in the alveoli of the lungs. They lower the work of breathing by reducing the surface tension and also form 
a line of defense against particles small enough to enter the respiratory tract. A deficiency of LS may lead 
to the fatal Neonatal Respiratory Distress Syndrome [NRDS] in premature infants, whereas, an impairment 
may cause Acute Respiratory Distress Syndrome [ARDS], irrespective of the age. Medical intervention in 
the form of Surfactant Replacement Therapy [SRT] becomes a lifesaver in such cases. Developing synthetic 
LS with efficacy in treating ARDS has therefore been a focus of this work. Further, with the rapid 
development in commercial and biomedical applications of engineered nanoparticles (ENPs), concerns 
regarding the effect of inhaled nanoparticles on LS function also need to be addressed. In this work, we 
have used a carbon-based ENP to understand their interactions with model LS. Our studies revealed that 
the alkyl chain saturation and head group charge of the phospholipids that form the major components 
of the LS play modulate phospholipid-nanoparticle interactions. We monitored the effect of Engineered 
Carbon Nanodiamonds [ECN] on five lipid compositions. In a zwitterionic environment, the nanoparticle 
was line active and favored the phospholipid domain boundaries. However, in an anionic environment, 
the nanoparticles reduced the packing density between domains. The electrostatic charge interaction was 
found to be more dominant.  
We also observed the tug of war between a synthetic surfactant protein (analog of natural 
surfactant protein, SPB) called MiniB and cholesterol. MiniB increased the line tension of the domains 
whereas cholesterol reduced the same. MiniB also helped in forming reversible collapse at low surface 
tension, which in turn saved material loss to the bulk. A lower concentration of both proved to be effective 
in increasing the surface activity of LS.  
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Introduction 
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1.1 Introduction 
Lung surfactants [LS] are a complex mixture of lipids and proteins that are present in the alveolar lining of 
the lungs [1]. The primary function of LS is to lower surface tension to near zero mN/m with expiration 
[2]. This is of utmost importance as a large pressure is needed to ventilate the lungs and therefore, in the 
absence of lung surfactants, smaller alveoli would collapse to larger ones, leading to uneven ventilation 
and the lungs would eventually collapse. LS essentially reduce the energy involved in breathing as lesser 
pressure is needed to inflate smaller alveoli. The smaller alveoli in turn, ensure a large surface area which 
enables greater gas exchange. These, along with the other functions, have been elaborately presented by 
Frerking et. al [3]. Fig1.1 shows a simplified diagram of alveoli [4]. The monolayer of lung surfactant lipids 
form at the air-water interface. Apart from lowering surface tension, LS can also play a role in immune 
response [5]. Any foreign particle that can enter lungs, interacts with LS. Thus, nanoparticles that can be 
used for the purpose of drug delivery, can encounter these surfactants and interact either favorably or 
adversely; a topic that will be covered in greater details in chapter 3.  
 
 
 
 
 
Figure 1.1: A simplified diagram of the alveoli showing the aqueous interface which contains the lung 
surfactants [adapted from ref. 4]. (Please note that the surfactant contains other lipids along with 
proteins).   
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Naturally, an absence or dysfunction of LS is a cause of concern as it may become fatal. Many infants born 
premature, fail to produce LS on their own, which leads to Neonatal Respiratory Distress Syndrome [NRDS] 
[6]. In USA itself, a high percentage of low weight infants are diagnosed with NRDS (around 70% during 
the 90s) and across the world, NRDS contributes to about 40% of the mortality of children younger than 
5 years [7]. A dysfunction in LS has also been reported to be associated with Acute Respiratory Distress 
Syndrome [ARDS]/ Acute Lung Injury [ALI] and each year, around 50,000-190,000 such cases are reported 
in USA [8]. Medical intervention in the form of Surfactant Replacement Therapy [SRT] is needed to take 
measures against such diseases and thus, great attention has been put into understanding the 
composition of LS and the interaction between the different components.   
LS is composed of around 80% phospholipids [9]. The primary component of the phospholipids is 1,2-
dipalmitoyl-sn-glycero-3-phosphocholine  (DPPC). DPPC is a zwitterionic lipid with two saturated, 
hydrophobic chains of palmitic acid. The saturated chains allow the monolayers of the surfactants at the 
air-water interface of the alveoli to compress to very low values of surface tension before the film 
collapses. This is possible as the saturated chains can assemble to highly ordered state of existence. Thus, 
these saturated lipids play a crucial part in lowering surface tension in the lungs. Although the saturated 
lipids can efficiently lower surface tension, they fail to get adsorbed quickly to the surface. Quick 
adsorption to the surface is much needed in order to prevent any delay in the process of breathing. Thus, 
LS also comprises of unsaturated lipids that cannot assemble to a highly packed form. However, they can 
be easily adsorbed to the surface and also help the LS to spread rapidly. These features are vital and make 
the compositions of the LS dynamic. The head-groups of the phospholipids are hydrophilic and remain 
soluble in the aqueous lining of the alveoli. Around 85% of the phospholipids are Phosphatidylcholine (PC) 
which is zwitterionic. About 9% of the phospholipids are Phosphatidylglycerol (PG) which has a net 
negative charge. A minute quantity of zwitterionic, Phosphatidylethanolamine (PE, 3%) and negatively 
charged phosphatidylinositol (PI, 2%) are also present in LS. Other than the phospholipids, around 10% of 
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the surfactants contain neutral lipids, primarily cholesterol, and some amount of free fatty acids and 
triglycerides. Cholesterol plays a part in improving the fluidity of the lung surfactant mixture and will be 
discussed in depth in chapter 2 where the interaction of cholesterol with an artificial surfactant protein 
called Mini B has been studied. The structures of the lipids used in the study are shown in Fig 1.2. 
 
Figure 1.2: Phospholipids, DPPC, DPPG, POPC and POPG, which were used in the study. The structures 
were adapted from Avanti Polar Lipids, inc.  
The remaining 10% of the surfactants are the proteins, namely SPA, SPB, SPC and SPD [9]. Among these, 
SPA and SPD are hydrophilic proteins [9]. SPA plays a part in homeostasis as well as surfactant turnover. 
The functions of SPA and SPD were discussed in details by Kishore et. al. [10] and both these large proteins 
are involved in immune response. On the other hand, SPB and SPC are hydrophobic in nature and  help in 
forming and maintaining the surfactant films at the air-water interface [11].  Even though the exact 3D 
structure of SPB is unknown, studies have shown that it is mainly alpha helical (40-45%) with 79 amino 
acids. In a monolayer containing LS phospholipids, SPB attaches itself to the liquid-expanded region 
making the condensed domains smaller in size but greater in number which gives stability to the cell. SPB 
is also charged, having 9 positively amino acid residues, which is believed to interact with the anionic 
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headgroup of the phospholipids [12]. We are particularly interested in SPB, because Mini B, the synthetic 
protein that we have studied, is an analog of the naturally occurring surfactant protein SPB. Fig 1.3 shows 
the hypothesized structure of SPB based on data from the indirect techniques, such as Circular Dichroism, 
Spin-resonance, infrared spectroscopy and Fluorescence anisotropy. During compression of the 
monolayer, as we breathe out, unsaturated lipids squeeze out of the surface and SPB is believed to 
interact with them, holding them close to the surface which has been shown in Fig 1.3 B.    
 
 
 
 
Figure 1.3: A) Hypothesized structure of SPB. The green lines show the disulphide links which stabilizes 
the dimers. B) SPB holds the squeezed out lipids close to the monolayer during compression preventing 
material loss. [Adapted from ref. 12] 
In Chapter 2 we discuss the results of our study focused on understanding the role of phospholipid 
composition in modulating phospholipid interactions with a model nanoparticle system with wide 
biomedical applications, namely, Engineered Carbon Nanodiamonds [ECN]. In chapter 3 we describe our 
assessment of the role of a synthetic lung surfactant protein called Mini B in countering the adverse effects 
of cholesterol, which is a highly debatable component in Surfactant Replacement Therapy [SRT].  
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Chapter 2 
 
Phospholipid Composition Modulates Carbon Nanodiamond- 
Induced Alterations in Phospholipid Domain Formation* 
 
 
 
 
 
*Adapted from Chakraborty, A., et al., Phospholipid Composition Modulates Carbon Nanodiamond-
Induced Alterations in Phospholipid Domain Formation. Langmuir, 2015 31(18): p. 5093- 5104. 
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2.1 ABSTRACT  
The focus of the work described in this chapter is to elucidate how phospholipid composition can 
modulate lipid nanoparticle interactions in phospholipid monolayer systems. We report on alterations in 
lipid domain formation induced by anionic engineered carbon nanodiamonds (ECNs), as a function of lipid 
headgroup charge and alkyl chain saturation. Using surface pressure vs. area isotherms, monolayer 
compressibility and fluorescence microscopy, we found that anionic ECNs induced domain shape 
alterations in zwitterionic phosphatidylcholine lipids, irrespective of the lipid alkyl chain saturation, even 
when the surface pressure vs. area isotherms did not show any significant changes. Bean-shaped 
structures characteristic of dipalmitoylphosphatidylcholine (DPPC) were converted to multilobed, fractal 
or spiral domains as a result of exposure to ECNs, indicating that ECNs lower the line tension between 
domains in case of zwitterionic lipids. For membrane systems containing anionic phospholipids, ECN 
induced changes in domain packing were related to the electrostatic interactions between the anionic 
ECNs and the anionic lipid headgroups, even when zwitterionic lipids are in excess. By comparing the 
measured size distributions with our recently developed theory derived by minimizing the free energy 
associated with the domain energy and mixing entropy, we found that the change in line tension induced 
by anionic ECNs is dominated by the charge on the condensed lipid domains. Atomic force microscopy 
images of the transferred anionic films confirm that the location of the anionic ECNs in the lipid 
monolayers is also modulated by the charge on the condensed lipid domains. Since biological membranes 
such as lung surfactants, contain both saturated and unsaturated phospholipids with different lipid 
headgroup charges, our results suggest that when studying potential adverse effects of nanoparticles on 
biological systems, the role of lipid compositions cannot be neglected.  
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2.2 Introduction: 
Recent advances in the field of nanotechnology have led to increased use of engineered nanoparticles 
(ENPs) in commercial applications such as electronic components, cosmetics, surface coatings, scratch-
free paints, as well as biomedical applications such as targeted drug delivery [1, 2]. The small size of these 
engineered nanoparticles leads to altered chemical reactivity when compared with their bulk 
counterparts. Additionally, their extremely small size makes ENPs increasingly capable of entering the 
human body either through environmental exposure or intentionally by inhalation, ingestion, skin 
penetration or being directly injected as in the case of several medical applications. While their altered 
chemical reactivity and small size make ENPs desirable for multiple commercial and medical applications, 
their potential toxic impact on biological materials, living organisms, and the environment is not yet well 
understood and is therefore a cause for concern [3].   
The respiratory route represents a unique portal of entry for inhaled nanoparticles, resulting in their 
accumulation in the lung. It has long been known that nanoparticles with hydrodynamic radius 10-20 nm 
are predominantly deposited in the alveolar regions, where they are expected to interact with lung 
surfactants (LS), a mixture of lipids and proteins that are together responsible for maintaining a low 
surface tension in the lung and prevent collapse [4-6]. However, analysis of the nanoparticle deposition 
has also shown that these smaller nanoparticles are often exhaled out during expiration. Rather, 
nanoparticles and nanoparticle agglomerates of size ranges 0.1-2 µm are more likely to be retained in the 
alveolar regions [7, 8]. As a result, the last few years have seen an increase in studies focused on the 
biophysical interactions of LS with polymeric and metallic nanoparticles of different composition, size, 
surface potential, or modified surface chemistry. Unfortunately, many of these studies have 
demonstrated contradictory effects of the nanoparticles on LS, as summarized below.  
Galla and co-workers, have reported concentration dependent adverse effects of hydrophobic 
polyorganosiloxane (AmOrSil20) on the surface tension lowering ability of a model LS. They observed an 
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increased fluidization of the  phospholipid monolayers due to interaction with the hydrophobic 
nanoparticles [9]. In a follow-up article, this group used high resolution microscopy imaging to further 
show that the AmOrSil20 nanoparticles influence the insertion of surfactant vesicles into the air/lipid 
interface in a concentration dependent manner, possibly by associating with surfactant associated 
reservoirs of LS at higher nanoparticle concentrations and surfactant packing [10], while associating with 
fluid regions of the film at lower surface pressures.  More recently, these authors have also provided 
evidence of molecular rearrangement of model LS around these hydrophobic nanoparticles [11], which 
may also be effected by the size of the hydrophobic nanoparticles [12]. Similarly, Zuo and coworkers have 
not only demonstrated time dependent adverse effects of hydroxyapatite nanoparticles on surfactant 
vesicles of a clinical surfactant Infasurf [13], but also demonstrated a difference in their translocation 
propensity through lipid monolayers [14]. In contrast, Beck-Broichsitter et al. reported that polystyrene 
nanoparticles of size 100 nm demonstrated no change in the surface tension lowering ability of another 
clinical surfactant (Alveofact) at a range of different concentrations [15]. Further, Farnoud et al. showed 
that 200 nm sized carboxyl modified polystyrene particles had opposite effects on the packing of 
dipalmitoylphosphatidylcholine (DPPC) films depending on their mode of exposure. When nanoparticles 
were injected below a preformed DPPC film, no penetration of the nanoparticles was noted. However, 
when the phospholipid was spread on a nanoparticle laden sub-phase, significant alteration of the DPPC 
packing was observed. The authors suggest that the sequence of particle and monolayer addition may 
influence nanoparticle−lipid interactions [16].  
Adverse effects of metallic nanoparticle-lung surfactant lipid interactions  on the surface tension lowering 
ability was reported for TiO2 nanoparticles of size ~5 nm, but not for microparticles of TiO2 [17, 18], 
suggesting that the size of these metallic nanoparticles contribute to their interactions with lipids. Along 
similar lines, Kodama et al., recently presented evidence of existence of a critical particle size range that 
effects the phospholipid domain packing of a model lung surfactant [19].  Bakshi et al. reported that bare 
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gold nanoparticles of size 15 nm impeded the ability of model lung surfactants to lower the surface tension 
[20], and led to aggregation of surfactant protein SP-B, preventing efficient adsorption of surfactant to 
the air/water interface. Contrary to these results, Tatur and Badia demonstrated a contrasting behavior 
in case of pure or mixed phospholipid monolayers exposed to hydrophobic alkylated gold nanoparticles 
of average core diameter 2 nm [21]. Their results indicated that even though these functionalized gold 
nanoparticles did not alter the surface tension lowering ability of lung surfactants, they altered the shape 
and size of liquid-condensed domains in DPPC films, that was used as a model protein-free LS. 
Interestingly, no adverse effects were seen for a clinical surfactant, Survanta [21] (containing both 
saturated and unsaturated lipids as well as surfactant proteins) even at nanoparticle concentrations that 
were two orders of magnitude higher than in the case of exposure to DPPC. These results suggested that 
the composition of lipid monolayers, and association of gold nanoparticles with the lipid domains played 
a dominant role.   
The contrasting results of the effect of nanoparticles on phospholipid packing in model lung surfactant 
function and particularly, the potential role of surfactant composition on lipid nanoparticle interactions 
form the major motivations for this study. While the effect of the shape, size and surface chemistry of the 
nanoparticles themselves have been studied in detail, to the best of our knowledge the effect of lipid 
headgroup charge and lipid saturation on nanoparticle induced changes in lipid domain formation and 
lipid packing is currently unknown. Therefore, the focus of this work is to understand how differences in 
lipid composition alter their interactions with nanoparticles. In particular, we report on the alterations in 
lipid domain packing of five different lipid compositions with different alkyl chain saturation and 
headgroup charge (Table 2.1) induced by surface modified engineered carbon nanodiamonds (ECNs) with 
a net negative charge.The choice of lipids is explained in detail in the discussion section and aims to reflect 
the major phospholipid headgroups (phosphatidylcholine, PC and phosphatidylglycerol, PG) in native and 
synthetic LS mixtures. Since both saturated and unsaturated lipids are essential for proper functioning of 
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LS, our choice of lipid compositions also reflects the alkyl chain saturations present in LS. ECNs were picked 
as our choice of nanoparticles since they have recently received a lot of attention due to their potential 
applications in drug delivery, biomedical imaging and tissue engineering applications [22] and are 
regularly used by co-author Forrest for in vivo applications [23, 24]. Therefore, understanding the 
fundamental physical rules governing lipid-nanapoarticle interactions using these nanoparticles are 
significant from a nanotoxicity perspective.  
 
Table 2.1: List of phospholipid combinations studied along with their overall charge and saturation.  
Sample  Saturated  Net charge  
DPPC  Yes  Neutral 
DPPG  Yes  Anionic 
DPPC:DPPG (75:25)  Yes  Anionic 
DPPC:POPC (7:3)  No  Neutral 
DPPC:POPG (7:3)  No  Anionic 
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2.3 Materials and Methods:  
2.3.1 Materials: Phospholipids dipalmitoylphosphatidylcholine (DPPC), dipalmitoyl phosphatidylglycerol 
(DPPG), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-
phospho-(1'-rac-glycerol) (POPG) used in this study were purchased from Avanti Polar Lipids (Alabaster, 
AL) as organic mixtures in chloroform at a final concentration of 5 or 25 mg/ml. Texas Red® 1,2-
dihexadecanoyl-sn-glycero-3-phosphoethanolamine, triethylammonium salt, TXR-DHPE, lipid dye was 
purchased in the dried form from Life Technologies (Invitrogen, Grand island, NY) and dissolved in high 
performance liquid chromatography (HPLC) grade chloroform (final concentration of 0.5 mg/ml). All 
organic solvents used for this work were purchased from Thermo Fisher Scientific Inc. (Pittsburgh, PA). 
The sub-phase water (resistivity 18.2 MΩ/cm) was prepared using a Millipore Gradient System (Billerica, 
MA). The lipid mixtures were stored at -20 ᵒC when not in use to ensure no evaporation of the organic 
solvent. The carbon nanodiamonds used in this study were obtained from Microdiamant, Lengwil, 
Switzerland.  
2.3.2 Methods:  Stock solutions of pure DPPC or DPPG, or mixed phospholipids of DPPC:DPPG, 
DPPC:POPC, DPPC:POPG in the ratio 70:30 molar ratio for DPPC:POPC and DPPC:POPG and 75:25 molar 
ratio for DPPC:DPPG were mixed with 0.5 mol % of TXR-DHPE dye in HPLC grade chloroform:methanol 
(4:1) mixtures. The ratio of 7:3 was selected primarily because many synthetic lung surfactant mixtures 
contain this ratio of PG. Stock solutions of the ECN were prepared by suspending the ECNs initially in water 
and in the methanol chloroform mixture and allowing the solution to sonicate for two hours. Immediately 
at the end of the sonication process, the particle size and zeta potential (for the aqueous sample) of the 
samples was measured using dynamic light scattering (NanoBrook Omni, from Brookhaven Instruments 
Corporation). The particle size was also measured in the presence of phospholipids in the organic solution. 
For these samples, stoichiometric volumes of the ECN were added to the organic lipid solution 
immediately after sonication, and used for particle size analysis or for the Langmuir trough experiments 
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described below. Table 2.2 shows the particle size distribution, obtained using the Smoluchowski equation 
that is built into the software. Our results showed that the carbon nanodiamonds formed aggregates of 
effective size 219 nm (average of three measurements), with a polydispersity of 0.19 when dispersed in 
water while the effective size of the aggregates in the organic mixture used for further experiments was 
found to be 235 nm with a a polydispersity of 0.35 . Further, we found that this aggregate size did not 
change within the first half hour after sonication, ensuring that the particle size did not change during the 
experiment. The zeta potential was measured using a 1.0 mM KCl solution, and was found to be -28 mV. 
The anionic nature of the ECN surface is a result of the interactions of these nanodiamond powders with 
air or ozone (during the purification process), which typically results in the presence of COOH groups on 
the ECN surface [22]. This anionic nature of the ECNs enables several surface modifications that are 
advantageous for various delivery-based applications [22].   
To initiate each experiment on the Langmuir trough, the lipid/nanoparticle mixture was made in 
chloroform:methanol mixture (4:1) and was added drop-wise from a Hamilton glass syringe onto a water 
sub-phase equilibrated to a temperature of  22 ᵒC at a pH of 5.6, contained in a ribbon Langmuir trough 
(Biolin Scientific Inc.) of maximum area 166 cm2 and minimum area 46 cm2. In these experiments, water 
was chosen as the sub-phase of choice to eliminate the effect of cations on the phospholipid packing, and 
to compare and contrast our results with previous biophysical measurements using similar phospholipid 
systems where water was chosen as the sub-phase [9, 21, 25, 26]. The moveable ribbon allowed controlled 
compression and expansion of the lipid monolayer formed at the interface, serving as an in vitro model 
mimicking change in alveoli area during inhalation and exhalation. Only the compression cycle is shown 
here. The trough is computer controlled using the trough control software from at Biolin Scientific. After 
spreading the sample, the solvent was allowed to evaporate by waiting for 20 minutes before any 
compression was started.  In this study the monolayer compression rate was kept at 7.0 cm2/minute. This 
rate is slow enough to allow time for simultaneous focusing on the monolayer film during compression 
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and also mimic a quasi-static compression rate. Compression studies were also conducted at 125 
cm2/minute, to ensure that the changes in the isotherms were not dependent on the rate of compression. 
A wet calibrated filter paper was used as a Wilhelmy plate balance allowing continuous recording of the 
surface pressure during the compression/expansion cycles. The Langmuir trough was mounted on a 
custom modified Nikon Eclipse fluorescence microscope with motorized focusing to allow continuous 
monitoring of the surface morphology during film compression. A 40x long working distance objective 
designed for fluorescent light was used to view the lipid monolayer film. A dichroic mirror/barrier filter 
assembly directed the excitation light onto the monolayer films at a normal angle of incidence and filtered 
the emitted light. The images were detected by a fast CCD camera (Andor LUCA) and short image 
sequences (5 frames) were recorded at every 1-5 mN/m surface pressure interval depending on the 
sample and the surface pressures. 
Table 2.2: Particle size analysis of the ECNs in different media relevant to the experimental conditions. 
ECN 
in  
Particle Size 
(nm)  
Poly-dispersity  
Water  219  0.19  
Chloroform/ methanol mixture  240  0.35  
Lipid/organic mixture  130  0.41  
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2.4 Theory:  
2.4.1 Compressibility Modulus: The compressibility of a lipid monolayer is sometimes used to describe 
monolayer mechanical properties. The isothermal two-dimensional bulk modulus of a material can be 
described as the material’s ability to store mechanical energy as stress. Mathematically, this two-
dimensional bulk modulus, β is defined as: 
    (1). 
The inverse of β is defined as the isothermal compressibility, κ, and is often used to quantify mechanical 
properties of lipid monolayers. Note that β and κ are both 2nd order derivatives of the free energy, G. 
 
discontinuous change at which  or  ) signifies a first order phase transition. In addition, a 
higher incompressibility suggests the formation of condensed well-packed films, and is essential for 
proper functioning of LS. For our experimental results, the compressibility modulus was calculated by 
taking the derivative of the surface pressure vs. area isotherms using in-built functions in Origin 8.62. The 
data was smoothened using a FFT filter over 5 points for all points except near the monolayer collapse 
region.  
2.4.2 Calculation of line tension changes from domain size distribution: It is now well-known that lipid 
molecules at the interface undergo lateral organization of the molecules to form domains [27]. Theoretical 
and experimental work by McConnell and co-workers have shown that distribution of domain sizes and 
shape in monolayers is a result of a balance between the interfacial energy at the domain edges (line 
tension) and electrostatic interactions between domains [28-30]. The difference in lipid chain lengths 
between the liquid-ordered (𝑙𝑜) and liquid-disordered (𝑙𝑑) phases (or liquid condensed (LC) and liquid 
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expanded (LE) phases in case of monolayers) leads to a line tension, , proportional to the hydrophobic 
mismatch between domains and the interfacial tension of the hydrocarbon-air interface ( ∝ (𝑙𝑜 − 𝑙𝑑)𝛾). 
Similarly, a difference in the packing density and composition between lipid phases results in a change in 
the average dipole density (∆𝑚2 = 𝑚𝑜 − 𝑚𝑑) due to electrostatic repulsion between and within the 
domains. This electrostatic repulsion in turn leads to changes in the electrostatic energy of the film. 
However, these parameters are often difficult to measure, particularly in the presence of small impurities, 
such as the ECN in this work. We have previously demonstrated a technique to calculate the line tension 
and dipole density difference of phospholipid domains by comparing the measured size distributions with 
a theory derived by minimizing the free energy associated with the domain energy and mixing entropy 
[31, 32]. In these systems we assume that the domains are in equilibrium. Briefly, for a circular domain, 
the radius of the domain (R) is related to the energy E by the equation: 
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In this expression, line tension, λ, between the domains of area a0 promotes fewer, larger domains, and 
the dipole density difference, m2, (C/m) between the domains, promotes smaller, more numerous 
domains, Δ is a length on the order of molecular dimensions, ~ 1 nm, ε is the dielectric constant of water 
(~80) and ε o, the permittivity of free space (= 8.854 x 10- 12 C2/J-m) [28]. N is the number of molecules with 
radius R, and can be given by minimizing equation 2 shows that minimum energy radius, Ro, for an isolated 
domain is:  
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However, our results demonstrate that the lipid domains at interfaces are polydisperse, and do not alter 
their shapes for several hours. This observation suggests the role of entropy of mixing, leading to a domain 
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size distribution. Assuming ideal entropy of mixing (i.e. no interactions between domains), and equality 
of the chemical potential of lipid condensed domains of radius R or R0, we have shown  that one can write 
an equation for the number fractions of domains (CN,M) with N (radius R) or M (radius Ro) molecules, in 
terms of the radius of the domains of molecules N and M [31]:   
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Equation 4 is used to fit the experimentally obtained domain size distributions, using CM, 
kT
Rm
 0
0
2
4

,  and 
R0, as the three fitting parameters (fits of adjusted r-squared values greater than 0.8 were accepted as 
good fits). Equation 3 is then used to calculate the line tension.   
2.4.3 Image Analysis: All fluorescence microscopy images were analyzed using ImageJ (NIH). To calculate 
the total change in the packing of the lipid ordered domains, change in the area fraction of the ordered 
condensed domains (the dark domains in the images) is calculated using the following equation:  
𝐶ℎ𝑎𝑛𝑔𝑒 𝑖𝑛 𝐶𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑑 𝐴𝑟𝑒𝑎 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛
=  
𝐶𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑑 𝐴𝑟𝑒𝑎 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑜𝑓 𝐶𝑜𝑛𝑡𝑟𝑜𝑙 − 𝐶𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑑 𝐴𝑟𝑒𝑎 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑤𝑖𝑡ℎ 𝐸𝐶𝑁 
𝐶𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑑 𝐴𝑟𝑒𝑎 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 𝑜𝑓 𝐶𝑜𝑛𝑡𝑟𝑜𝑙
 
where:  
𝐶𝑜𝑛𝑑𝑒𝑛𝑠𝑒𝑑 𝐴𝑟𝑒𝑎 𝐹𝑟𝑎𝑐𝑡𝑖𝑜𝑛 =  
𝐴𝑟𝑒𝑎 𝑜𝑓 𝐷𝑎𝑟𝑘 𝐷𝑜𝑚𝑎𝑖𝑛𝑠
𝑇𝑜𝑡𝑎𝑙 𝐴𝑟𝑒𝑎 𝑜𝑓 𝐹𝑟𝑎𝑚𝑒
 
The domain size distribution is plotted as normalized histograms with the width of the size distribution 
being set by dividing the maximum measured domain size by the square root of the number of domains 
analyzed,  n1/2. The minimum resolved domain radius was set to be 0.5 µm, which was determined by the 
resolution of the optical microscope.To improve the statistics, two neighboring frames were analyzed. To 
represent the histogram as a probability distribution, we represent the number of domains as a relative 
frequency. Using the Nonlinear Curve Fit feature of Origin 8.6, the domain size distribution of DPPC:DPPG 
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and DPPC:POPG domains with and without ECNs were fit to Equation 4, and the fitting parameters used 
to calculate the line tension of these monolayers.  
2.4.4 Atomic Force Microscopy (AFM): The location of the ECNs in the anionic lipid monolayers inferred 
from the domain size distribution of DPPC:DPPG and DPPC:POPG domains with and without ECNs were 
correlated with high resolution AFM images of the phospholipid films at a surface pressure of 20 mN/m 
transferred onto a freshly cleaved mica substrate . A home-built inverse Langmuir-Schaffer technique 
similar to the technique developed by Lee et al. was used for the film transfer process [33]. This technique 
allows visualization of the film during the transfer process, to ensure that there were no perturbations in 
the domain distribution during the transfer process. Briefly, the mica substrate was placed on an 
aluminum holder with machined knife-edges following the design of Lee et al [33]. This whole apparatus 
was first thoroughly cleaned and then placed on the bottom of the trough, and kept submerged during 
the compression cycle. When the desired surface pressure was reached, the water was very slowly 
aspirated, until the knife-edge cut the monolayer, and let it fall onto the substrate. The focus was re-
adjusted throughout the process to ensure that the surface was always visible.  
The transferred monolayers were imaged at the ambient temperature in air using a Veeco diMultimode 
V microscope. A J-scanner with an X-Y scan range of 125 by 125 µm was used in the tapping mode using 
Antimony doped Silicon probes (Bruker Scientific) with a resonant frequency of 371 kHz. Images were 
collected at a scan rate of 1 µm/sec at a resolution of 512 pixels/line. The images were later flattened 
using the in-built software to compensate for sample tilt (raised features were excluded from this 
flattening). The captured images were exported and saved for further use and height analysis.  
 
 
 
 
21 
 
2.5 Results:  
2.5.1 Isotherms: 
2.5.1.1 Isotherms of DPPC: Figure 2.1A shows a quasi-static surface pressure vs. mean molecular area 
isotherm for a DPPC film containing 1.0 wt% (10 µg /ml) of ECN. The averages of three sets are plotted. 
Surface pressure is defined as Π=γ0-γ, where γ0=72 mN/m for water, and γ is the measured surface tension. 
The red dashed line shows a characteristic surface pressure vs. mean molecular area of pure DPPC film. 
At very high area per molecule, the monolayer was in a gas phase, with a nearly zero surface pressure. As 
the area of the trough was decreased, the total area exposed to the molecules increased, which in turn 
caused the surface pressure to increase from zero. With increased compression, the film entered the 
liquid expanded (LE) phase, which was accompanied by a smooth increase in the surface pressure until a 
plateau was reached at Π= 7mN/m, corresponding to the start of the liquid condensed (LC) region. The 
presence of a plateau region on further compression of the trough was due to an increase in the fraction 
of LC domains at the expense of the LE phase at a nearly constant surface pressure (co-existence plateau). 
At the end of this coexistence plateau, the surface pressure increased almost linearly with decreased 
molecular area, until the film underwent collapse at a surface pressure ~72 mN/m. The black dashed dot 
curve shows the measured surface pressure vs. mean molecular area after the DPPC film had been 
incubated with ECN. No significant changes in the collapse surface pressure or the surface pressure 
corresponding to LE/LC coexistence plateau were noted when the DPPC solution was incubated with 1.0 
wt. % (10 µg /ml) ECN. However, the addition of ECN did cause a shift of the curves to smaller mean 
molecular areas occupied by the lipid molecules, suggesting that the ECNs have a condensing effect on 
the DPPC domains.  
2.5.1.2 Isotherms of DPPG: Figure 2.1B shows a typical surface pressure vs. mean molecular area isotherm 
for a DPPG film containing 1.0 wt. % (10µg/ml) of ECN. As expected, based on previous reports, pure DPPG 
film (red dashed curve) at room temperature did not show an explicit LE/LC coexistence plateau seen for 
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DPPC. Vollhardt et al. showed that this is because  DPPG films on a pure water sub-phase already existed 
as a LC phase at surface pressure of 0 mN/m [34]. Upon compression, the surface pressure increased 
sharply until the film underwent monolayer collapse at a surface pressure of around 60 mN/m. Adding 
1.0 wt. % (10 µg/ml) ECN did not alter this surface pressure vs. area isotherm.  
2.5.1.3 Isotherms of DPPC:DPPG: DPPC:DPPG was used as a model lipid system containing a net negative 
charge due to the PG headgroup, while the alkyl tail length and tail saturation was the same for both the 
lipids. This model mixture has previously been used by Harishchandra et al. to study the effect of 
hydrophobic AmOrSil20 on model lipid films. As seen in Figure 2.1C, the characteristic surface pressure 
vs. mean molecular area isotherm (red dashed curve) resembled that of a pure DPPG film, with no LE/LC 
coexistence region typical of a DPPC film, but had a collapse surface pressure corresponding to a DPPC 
film. No changes in the pressure area isotherms were observed when 1 wt % (10 µg/ml) of ECN was added 
to this lipid mixture (black dash dot line).  
2.5.1.4 Isotherms of DPPC:POPC: Introduction of unsaturated POPC molecules with mixed alkyl chains 
alters the ability of DPPC molecules to form well-packed structures. As a result, the addition of POPC 
significantly alters the surface pressure vs. mean molecular area isotherms compared to a characteristic 
DPPC film. As shown in the red dashed curve in Figure 2.1D, the LE/LC coexistence plateau was not present 
at surface pressure ~7 - 9 mN/m;  however, a shoulder appeared at a surface pressure of ~42 mN/m, 
corresponding to the collapse pressure of pure POPC films. This shoulder corresponds to the “squeeze-
out” pressure in LS, and causes the pure DPPC film remaining at the interface to reach the ultra-low 
surface pressures desirable for healthy breathing [31].  The black dash dot curve demonstrates the 
isotherm obtained for DPPC:POPC lipids mixed with 1 wt % (10 µg/ml) of ECNs. We found that the surface 
pressure vs. area isotherms obtained overlapped completely with the pure DPPC:POPC system.  
2.5.1.5 Isotherms of DPPC:POPG: Addition of anionic POPG with mixed alkyl chain saturation to the DPPC 
film caused both an increase in the fluidity of the membrane, as well as a net negatively charged lipid 
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monolayer. Figure 2.1E (red dashed curve) demonstrates that the LE/LC coexistence was found to occur 
at a surface pressure of about ~15-17 mN/m. Surface pressure vs. mean molecular area isotherms 
obtained from samples containing 1 wt % (10 µg/ml) ECNs, overlapped completely with the characteristic 
curves of the ECN-free control systems (black dash dot lines). 
2.5.2 Compressibility Modulus: Figure 2 shows the compressibility modulus as a function of mean 
molecular area for all the five samples described above. As seen in Figure 2.2A, at high mean molecular 
areas (> 75 Å2/molecule), the DPPC film demonstrated a gradual increase in the compressibility modulus 
to about 25 mN/m followed by a sharp dip at a mean molecular area of about 70 Å2/molecule. Beyond 
this dip, the compressibility modulus remained constant at a very small value until it shot up to 190 mN/m 
corresponding to monolayer collapse. ECN (black dashed curve) did not cause any significant alterations 
in the compressibility modulus, except at collapse where the maximum compressibility modulus was 
found to be higher (by 50 mN/m) in case of the lipid film containing ECN. Additionally, the position of the 
peak compressibility value also shifted to lower mean molecular areas. Figure 2.2B shows the 
compressibility modulus for DPPG films before and after adding ECNs. For the control system (red dashed 
curve), the lack of a significant discontinuity signifies absence of a first order phase transition in this 
system [25]. Addition of ECN showed almost overlapping curves with the control, except the absolute 
value of the maximum compressibility modulus, which was higher for the control. Figure 2.2C shows that 
for the DPPC:DPPG mixed lipid system, no change in the compressibility modulus was observed after 
adding ECN. Moreover, the position of the maximum shifted to lower mean molecular areas. Figure 2.2D 
shows that the compressibility modulus of a DPPC:POPC film (red dashed curve) did not alter due to ECNs. 
Figure 2.2E shows that no significant changes occur in the DPPC:POPG (red dashed curve) monolayer 
mechanical properties due to interactions with the ECNs (black dash-dot line).  
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2.5.3: Fluorescence Images: 
2.5.3.1 Fluorescence Images of DPPC monolayers incubated with ECNs:  Figure 2.3A represents a typical 
set of images showing the domain morphology of a pure DPPC monolayer at two different surface 
pressures:  4 mN/m, representative of the LE phase and 9 mN/m, representative of the LE/LC coexistence 
phase. In the LE phase, homogeneous mixing of the lipid dye caused the film to appear uniformly bright. 
However, this landscape quickly changed with the introduction of ECNs. Images obtained by spreading 
DPPC solutions mixed with ECN showed clusters of small circular dark domains. Contrast in these images 
is due to the selective segregation of bulky dye molecules in the more fluid regions, being excluded from 
the well-packed condensed domains that appear dark [34, 35]. In the LE-LC co-existence region, the pure 
DPPC film showed kidney bean shaped domains characteristic of DPPC. However, films formed after 
adding ECNs to the lipid solution started to cause alterations in the domain morphology. The kidney bean 
shaped domains started to aggregate to form multi-lobed structures while the net area of condensed LC 
domains increased, as shown in Figure 2.6A.  
2.5.3.2 Fluorescence Images of DPPG monolayers incubated with ECNs: Figure 2.3B shows fluorescence 
microscopy images of DPPG films at two different surface pressures (20 mN/m and 30 mN/m) before and 
after addition of 10 µg/ml ECNs. The images for the pure DPPG appeared dark because the film exists in a 
LC state at both of the surface pressures reported [25]. Our images show that adding ECNs caused the 
DPPG domains to reduce in size, but they were still very well packed. Further analysis of the changes in 
the LC domains is shown in Figure 2.7B.  
2.5.3.3 Fluorescence Images of DPPC: DPPG monolayers incubated with ECNs:  Since the effect of ECN 
interactions on lipid domain formation were significantly different in DPPC lipids compared to anionic 
DPPG films, we wanted to study what would happen when ECNs were introduced to a system containing 
both these lipids. Figure 2.4 is a representative set of images of our observations. We found that 
DPPC:DPPG films formed well-packed circular domains. Domains formed by DPPC:DPPG molecules 
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incubated with ECNs showed alterations in the size of the domains and also the domain packing, with 
more fluid regions being visible. Analysis of the domain size distribution (Figure 2.5) showed a decrease 
in the width of the domain size distribution and also a decrease in the minimum energy radius R0. Further, 
Figure 2.7 B shows that in this lipid environment, the ECNs induced significant decrease in the condensed 
area fraction.  
2.5.3.4 Fluorescence Images of DPPC: POPC monolayers incubated with ECNs: To further explore if the 
alteration in domain packing induced by the ECNs may be modulated by the presence of unsaturated 
lipids, we also studied the domain formation in a DPPC: POPC film. As noted before, the introduction of 
phospholipids with mixed alkyl chains like POPC increased the fluidity of monolayer when compared with 
a pure DPPC system, without altering the overall headgroup charge. Figure 2.6A summarizes our results 
at two different representative surface pressures (20 mN/m and 30 mN/m). The control systems indicate 
that the kidney-bean shaped domains characteristic of DPPC monolayers were still present, with more 
bright regions compared to a pure DPPC monolayer. Figure 2.7 shows that adding ECNs to the lipid 
solution caused alterations in both the domain shape and domain size distribution. At 30 mN/m, ECNs 
had similar effect as the pure DPPC system, where the domains developed fractals or spikes arising from 
the domains. Further, as shown in Figure 2.7B, the addition of ECNs to this system caused a decrease in 
the condensed area fraction of the domains.  
2.5.3.5 Fluorescence Images of DPPC: POPG monolayers incubated with ECNs: Finally, to test the effect 
of both lipid membrane saturation and electrostatic interactions between the anionic lipids and the 
anionic ECNs, we tested the formation of lipid domains in DPPC:POPG films containing ECNs. Introduction 
of POPG to DPPC films causes the appearance of circular domains which are not as well packed as films 
containing disaturated PG lipids, as shown in Figure 2.6B. It is well known that unlike the DPPC:DPPG 
system, the POPG molecules occupy the more fluid LE phase, while the DPPC domains make up the LC 
domains. While the addition of ECN did not show any visual change in the domain shape or the overall 
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fluidity, an analysis of the domain size distribution (Figure 2.5) showed that ECNs induced an increase in 
the minimum energy domain radius, and a decrease in the width of the domain size distribution.  
To further analyze the domain morphology of the different lipid systems, due to the presence of the ECN, 
we plot the change in the condensed domain fraction, as shown in Figure 2.7. A negative change indicates 
increase in the total condensed domain fraction, while positive values indicate a decrease. Interestingly, 
we find that apart from DPPC lipids (Figure 2.7A), all other lipid mixtures showed a decrease in the net 
dark domains (Figure 2.7B), although this value was almost negligible (~ 5%) for the DPPC:POPG mixture.  
We also calculated changes in the line tension of the two anionic lipid mixtures, as shown in Figure 2.9. 
We find that the presence of saturated PG lipids causes the ECNs to cause an increase in the line tension, 
while in the presence of unsaturated PG lipids, the line tension was found to decrease.  
2.5.4 AFM Images of DPPC: DPPG  and DPPC: POPG monolayers incubated with ECNs: Finally, in order to 
correlate the calculated changes in the line tension of the two anionic lipid mixtures with the location of 
the ECNs in the monolayers, we imaged the DPPC:DPPG and DPPC:POPG films transferred onto a mica 
substrate at a surface pressure of 20 mN/m. Figure 8 shows higher resolution images of the lipid domains 
in the absence (Figure 2.9A and 2.9B) and presence (Figure 2.9C and 2.9D) of  ECNs. The light brown 
regions correspond to LC domains, while the dark brown regions correspond to LE regions. The highly 
ordered lipid tails in LC domains causes LC domains to be slightly higher than the LE regions. Moreover, 
as noted earlier, the saturated DPPC and DPPG molecules form well packed LC domains, while the 
unsaturated POPG lipids occupy LE regions. As a result, Figure 2.8A shows more LC domains, while the 
DPPC:POPG film in Figure 2.9C shows circular, but less condensed regions. Further, Figures 2.9C and 2.9D 
show the appearance of raised features of height 30-50 nm and size 200 to 400 nm in lipid films containing 
ECNs. TEM images and DLS measurements described earlier suggest that even though the size of the ECNs 
in the dry powder state is 5-10 nm, thermodynamics causes these particles to exist as aggregates of size 
greater than 200 nm. Therefore, in the AFM images, the pink regions of height greater 20 nm and size 
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greater than 200 nm are attributed to ECNs. A height analysis of some of the raised features in Figures 
2.9C and 2.9D (E, F) are also presented for further information of the dimensions of these raised features.  
In case of the DPPC:DPPG films, these large raised features of height greater than 30 nm are away from 
the domain boundaries, whereas, for the DPPC:POPG films, these features appear along the domain 
boundaries. Figure 2.9C also shows a few raised features within the LC domains. However, a detailed 
height and size analysis shows that these regions within the LC domains are less than a couple of 
nanometers high (Fig 2.15), suggesting that these cannot be ECN aggregates that compose of spherical or 
diamond shaped particles of size 5-10 nm.  
 
2.6 Discussion:  
This research is motivated by the need to understand how lipid headgroup charge and lipid membrane 
fluidity modulate lipid/nanoparticle interactions leading to alterations in mechanical and structural 
properties of lipid monolayers. The effect of both positively and negatively charged nanoparticles on the 
packing of zwitterionic lipids have been explored both experimentally and theoretically [35, 36]. However, 
to the best of our knowledge, how the lipid membrane packing is altered by charged nanoparticles in 
zwitterionic, anionic or mixed zwitterionic/anionic lipids with differences in membrane fluidity is currently 
not well understood. Our experiments were designed to study both the effect of lipid headgroup charge 
and lipid chain saturation on lipid nanoparticle interactions. DPPC is the major phospholipid component 
of LS, while PG lipids form the second most abundant component in native LS. Moreover, native and 
synthetic LS also contain unsaturated lipids, to allow efficient adsorption of LS. Therefore, the lipids used 
in this study were carefully selected to represent these combinations. While the studies described here 
followed changes in the lipid domain packing due to incubation of lipid molecules with one concentration 
of ECNs (Fig 2.10, 2.11, 2.12) also show the effect of an order of magnitude higher ECN concentration on 
these biophysical characteristics. Even though the thermodynamic properties of the lipids are not always 
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significantly affected by the ECNs, both the lipid headgroup charge and lipid alkyl chain saturation can 
dramatically influence the overall lipid domain shape and size in these systems. Our results conclusively 
establish that in addition to the surface properties of nanoparticles, the biophysical properties of the lipid 
compositions can also significantly influence the nanoparticles tendency to alter the phospholipid packing. 
Below we discuss our results in more detail.  
2.6.1 Effect of lipid headgroup charge on lipid/ECN interactions in pure lipid systems: DPPC monolayers, 
with well characterized monolayer phases, were used as an example of a zwitterionic lipid with a net 
neutral charge, while DPPG was used as our model anionic lipid. The thermodynamic properties of both 
these systems are well characterized. The tail length of both these systems were chosen to be the same 
to ensure that the difference in lipid/nanoparticle interaction in these two pure systems is only as a result 
of differences in electrostatic interactions between the anionic ECNs and the net neutral or anionic 
phospholipid headgroups. While the isotherms for the DPPC films before and after adding ECNs did not 
show any significant alterations, the compressibility modulus slightly shifted to lower mean molecular 
areas and showed an increase in the maximum compressibility modulus. This increase implies that 
exposure with ECNs affected the overall mechanical properties of the DPPC films, and caused a possible 
condensation of the lipid domains. This possibility was explored further using fluorescence microscopy. 
Fluorescence microscopy is used to monitor molecular organization of lipid molecules in lipid monolayers 
[36], and the morphology of DPPC monolayers is now well established [28,37]. By comparing the domain 
morphologies of DPPC films before and after adding ECNs, we found that ECNs caused early nucleation of 
lipid domains. Further, an increase in the net condensed area was also measured, further confirming that 
the ECN caused a condensation of the lipid domains. Such an observation was also reported by Tatur and 
Badia, even though the physicochemistry of their gold nanoparticles is significantly different from our 
ECNs [31]. We also found that ECNs caused the characteristic bean-shaped domains of zwitterionic DPPC 
films to form more aggregated multilobed domains. Shape alteration in DPPC films from a kidney bean 
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structure to a more stretched out spiral structure indicates a lowering of the line tension between the LC 
domains and the surrounding LE regions [28, 38]. Such an alteration in domain shape has previously been 
reported when small amounts of cholesterol were added to a pure DPPC film [28,39]. Galla and co-workers 
found a similar effect with hydrophobic polymeric nanoparticles [9], while  Tatur and Badia observed a 
similar effect when studying interactions between alkylated Au NPs and DPPC films, where AFM images 
showed the presence of aggregates of AuNPs around condensed DPPC domains [21]. The lowering of line 
tension indicates that like the hydrophobic polymeric and gold nanoparticles, ECNs act as line active 
species that prefer to associate with grain boundaries in saturated zwitterionic lipid films, thus altering 
the phospholipid packing in these systems.   
Comparing the results for the effect induced by ECNs on a pure zwitterionic system compared to a pure 
anionic system like DPPG, we found that the isotherms and compressibility moduli overlapped completely 
for the systems with and without ECN, except that a decrease in the maximum compressibility modulus 
was noted. These observations suggest that the thermodynamic properties of the DPPG films were not 
affected by exposure to ECN, but the compressibility modulus was decreased, suggesting a slight increase 
in the membrane fluidity. Similarly, no significant changes were observed in the shape of well-packed 
large lipid domains of DPPG, after exposure to the ECNs. However, careful analysis of the condensed area 
fraction did show that ECN induced a decrease (~20%) in the total fraction of dark domains, indicating an 
increase in the membrane fluidity. McConell and co-workers have previously shown that domain 
morphologies are determined by a balance between the line tension between domains and electrostatic 
energies resulting from dipole interactions between domains [38]. The tendency to minimize line tension 
causes long stretched out domains, while minimizing dipole interactions causes break-up of larger 
domains into smaller sizes. Even though the domains were still well packed for the DPPG films, the 
decrease in the overall dark condensed domains, as well as the lack of spiral or multilobed domains in 
case of pure DPPG suggest that for the pure anionic saturated phospholipid systems these ECNs are no 
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longer line active species, but rather increase the overall fluidity of the monolayers. However, this change 
was subtle enough that it could not be detected in the compressibility isotherm.   
2.6.2 Effect of lipid headgroup charge and membrane packing on lipid/ECN interactions in mixed lipid 
systems: To further prove that the differences in the changes in lipid domain shape and size distribution 
induced by ECN was due to differences in the interactions with the different lipid headgroups, DPPC: DPPG 
(7:3) was used as a mixed saturated lipid system. In this system, the LC domains are net negatively 
charged, because of the tendency of DPPG to form LC phases even at very low surface pressure. If our 
hypothesis, stated above, is correct, we would expect that the anionic ECNs would be repelled by the 
anionic LC domains, causing an increase in the membrane fluidity. Further, repulsion from the domain 
boundaries would cause ECN to increase the line tension, due to repulsion from the lipid domain boundary 
[31]. Indeed, we experimentally measured that the ECNs induced a decrease in the condensed area 
fraction of domains. We also measured an increase in the line tension between domains for the 
DPPC:DPPG system, suggesting that the ECNs avoid the line boundaries. To further confirm this, we 
replaced DPPG with POPG molecules. Since POPG is unsaturated, unlike the DPPG molecules, it is expected 
to occupy the LE phases in the monolayer [31]. According to our explanation, this would suggest that in 
the presence of POPG, the ECNs would avoid the fluid LE phases and continue to prefer the condensed 
DPPC domains, which in turn would cause a lowering of the line tension. Indeed, we do measure a 
decrease in the line tension between domains for the DPPC:POPG films. This observation is also expected 
based on our previous observations of lipid-protein interactions [31]. We have previously reported that 
positively charged proteins caused an increase in line tension between domains in a clinical lung surfactant 
mixture, where the POPG molecules occupy the fluid LE regions. Finally, our AFM images provide concrete 
evidence of this hypothesis. Careful analysis of the location of raised features of height 20 nm or greater 
and sizes greater than 200 nm conclusively established that indeed the sub-micron sized ECN aggregates 
prefer the fluid LE phase in case of the DPPC:DPPG films, while they avoid the anionic LE phase and prefer 
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the LC domain boundaries in case of the DPPC:POPG films. Further, our data (Fig 2.12) shows that at higher 
ECN concentrations, the nanoparticles do cause a visible breaking of the circular domains into spirals, 
suggesting a further lowering of line tension. Similarly, changing the sub-phase from water to buffer 
accentuates the lowering of the line tension in DPPC:POPG films, as shownFig 2.14. Finally, we expect that 
if the LC domains retain their zwitterionic charge, the ECNs will continue to demonstrate their line active 
behavior. Again, this is what was experimentally observed for the DPPC:POPC monolayers. We observed 
that ECNs caused a decrease in the total condensed area as well, indicating that in the presence of 
unsaturated lipids, the ECNs lose their ability to nucleate and condense the DPPC domains. The reason for 
this is currently unclear, although one possibility is that at lower surface pressures the ECNs coexist with 
the unsaturated lipids, and are hence unable to serve as nucleation sites for domain condensation. Since 
the lipid morphology and line tension between domains have been shown to be related to the ability of 
lung surfactant films to resist collapse at ultra-low surface tensions,  potential for re-adsorption and 
respreading of lipid material after monolayer collapse, as well as membrane curvature in lipid bilayers 
(which in turn can be related to the stability of membranes) [31], we hypothesize that the same 
nanoparticles can demonstrate significantly different effects on the biophysical performance of different 
model lipid mixtures. Therefore, our results suggest that when reporting the potential adverse effects of 
nanoparticles, one should also consider the lipid headgroup charges, alkyl chain saturation and their effect 
on lipid/nanoparticle interactions. 
2.7 Conclusion: 
In conclusion, we report that phospholipid headgroup charge, lipid composition and lipid alkyl chain 
saturation modulate nanoparticle induced changes in lipid systems. We found that anionic ECNs were line 
active and interacted with lipid domain boundaries resulting in a lowering of line tension, when present 
in a zwitterionic environment. This observation is in line with prior results with hydrophobic metallic and 
polymeric particles. In addition, we found that in the presence of anionic phospholipids, electrostatic 
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repulsion between the domains dominated, and controlled the alterations in lipid domain packing induced 
by the ECNs, even in a mixed system with an excess composition of the zwitterionic lipid. While the effect 
of nanoparticles of different surface charge, surface modification and size on the packing of phospholipids 
have been described before, we present, for the first time, a controlled study to understand how 
physicochemical properties of lipids modulate lipid nanoparticle interactions.  
2.8 FIGURES: 
 
 
Figure 2.1: Surface Pressure vs. mean molecular area isotherms for (A) a DPPC (B) DPPG (C) DPPC:DPPG 
(75:25) (D) DPPC:POPC (7:3)  (E) DPPC:POPG (7:3) monolayers containing 1 wt % (10 µg/ml) ECN.  
 
   
(E) 
(A) (B) (C) 
(D) 
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Figure 2.2: Compressibility Modulus vs. mean molecular area isotherms for (A) a DPPC (B) DPPG (C) 
DPPC:DPPG (75:25) (D) DPPC:POPC (7:3)  (E) DPPC:POPG (7:3) monolayers containing 1 wt % (10 µg/ml) 
ECN.  
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Figure 2.3: Fluorescence Microscopy images of pure (A) DPPC and (B) DPPG monolayers before (Control) 
and after adding 1 wt % (10 µg/ml) ECN, at two representative surface pressures. Contrast in these images 
is due to the selective segregation of bulky phospholipid modified dye molecules into the more fluid 
regions. The kidney bean structures, characteristic of a pure DPPC system, underwent drastic transitions 
to more spiral shape due to interactions with the ECNs. The scale bar is 10µm. 
       
 
 
 
 
 
 
 
(A) (B) 
35 
 
 
 
 
 
 
 
 
 
Figure 2.4: Fluorescence Microscopy images of a mixed DPPC:DPPG (75:25) monolayer with a net anionic 
charge before (Control) and after adding 1 wt % (10 µg/ml) of anionic ECNs. A decrease in the domain size, 
and increase in number density was noted (Fig 2.13), but unlike a pure DPPC film, no change in the shape 
of the domains was observed. The scale bar is 10 µm.  
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Figure 2.5: Analysis of domain size distribution of DPPC:DPPG and DPPC:POPG monolayers in the absence 
(A,C) and presence (B,D) of ECNs. The red curve shows the fit to Equation 4 in the main text. The curve 
fitting yielded an average adjusted R-Squared value of 0.87, indicating the good quality of the fit. The 
fitting parameters are also shown.  
(C) 
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Figure 2.6: Fluorescence Microscopy images of a mixed (A) DPPC:POPC (7:3) monolayer with a net neutral 
charge and (B) DPPC:POPG (7:3) monolayer with a net anionic charge and unsaturated lipids before 
(Control) and after adding 1 wt % (10 µg/ml) of anionic ECNs. The scale bar is 10 µm. 
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Figure 2.7: Change in the condensed area fraction with the addition of ECN as a function of surface 
pressure. Positive values indicate a lowering in the area of the condensed region whereas a negative value 
refers to an increase in the area. (A) For DPPC, there was an increase in the domain area with the 
introduction of ECN and the change decreased sharply with the increase in surface pressure. (B) In case 
of DPPG, the condensed area fraction reduced as the negatively charged domains repelled the 
nanoparticles. A similar trend was observed for DPPC:DPPG. For DPPC:POPC, we recorded the highest 
reduction in area, but the change decreased with an increase in the surface pressure. Finally, we found 
very little change in the area for DPPC:POPG.  
 Figure 2.8: Changes in the line tension of (A) DPPC:DPPG and (B) DPPC:POPG at two different surface 
pressures in the absence and presence of 1 wt % (10 µg/ml) of ECN.    
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Figure 2.9: AFM images of the net anionic binary mixtures of phospholipid films transferred onto a solid 
mica substrate. (A, B): DPPC:DPPG films in the absence and presence of ECN respectively (C,D): 
DPPC:POPG films in the absence and presence of ECN respectively. (E,F) Show the height analysis of the 
raised features indicated by white lines in B and D.   
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Figure 2.10: Surface Pressure vs. area per molecule isotherms of (A) DPPC (B) DPPG (C) DPPC: DPPG (75:25) 
(D) DPPC:POPC (7:3) (E) DPPC:POPG (7:3) monolayers obtained after one hour of incubation with 1 wt % 
(10 µg/ml) and 10 wt% (100 µg/ml) ECN. 
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Figure 2.11: Compressibility Modulus vs. area per molecule isotherms for (A) DPPC (B) DPPG (C) DPPC: 
DPPG (75:25) (D) DPPC:POPC (7:3) (E) DPPC:POPG (7:3) monolayers obtained after one hour of incubation 
with 1 wt % (10 mg/ml) and 10 wt% (100µg/ml) ECN. 
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Figure 2.12: Comparison of ECN induced alterations in lipid domains as a result of exposure to different 
concentrations of ECN (A) DPPG (B) DPPC:POPG mixture.   
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Figure 2.13: TEM images of the ECNs originally suspended in water (A and B) and organic solvent (C and 
D) show that the ECNs have a tendency to aggregate into sub micron particle size in media, even though 
they are about 5-10 nm in the dry powder state. The aggregates show these individual particles in higher 
resolution images (B and D). Scale: A: 100 nm, B, D: 10 nm, C: 500 nm.  
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Figure 2.14: (A) Fluorescence images of DPPC:POPG films without and with ECN spread on a PBS buffer 
sub-phase at two representative surface pressures. (B) Line tension analysis from the domain size 
distributions in (A) show a significant decrease in the line tension in the presence of ECNs.  
CONTROL With ECN 
(B) (A) 
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Fig 2.15: Detailed height analysis within a condensed domain shows that unlike the significant height 
change in the LE phase, the raised features within the LC domain do not correspond to ECN aggregates of 
size ~ 250 nm, since the height of these features is significantly lower than that expected for ECN 
aggregates that contain carbon nanodiamonds of diameter 5-10 nm.  
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Chapter 3 
Synthetic Protein, MiniB, Counters the Effect of Cholesterol in 
a Simple Binary Mixture of Lung Surfactant Phospholipids at 
the Air-Water Interface 
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3.1 Abstract: 
Lung surfactants [LS], a complex mixture of lipids and proteins, play a crucial role in lowering the line 
tension at the air-water interface in the alveoli of the lungs, reducing the work needed for breathing and 
also improving lung compliance. A deficiency/ impairment of the lung surfactants may prove to be fatal 
making medical intervention with Surfactant Replacement Therapy [SRT] absolutely vital in such cases. 
However, there is yet to be a consensus on the composition of LS used in SRT, especially the interaction 
between the various components of the mixture. We aimed at understanding how Mini B, a synthetic 
analog of SPB, a hydrophobic surfactant protein,  interacts with cholesterol, which is a highly debated 
component, in the presence of a simple binary mixture of LS phospholipids, namely, 1,2-dipalmitoyl-sn-
glycero-3-phosphocholine (DPPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG) 
in the weight ratio 7:3. Based on surface pressure versus mean molecular area isotherms and fluorescence 
imaging under constant compression, we conclude that a low concentration of Mini B along with an equal 
concentration of cholesterol aids in the proper functioning of synthetic LS. Cholesterol prefers to stretch 
out the phospholipid domains by lowering line tension and also makes LS collapse irreversibly. On the 
contrary, a domain size distribution analysis reveals that Mini B increases line tension between the 
domains. Mini B also helps LS to collapse reversibly forming giant folds, therefore, preventing material 
loss from the interface. A tug of war ensues as the two are put together and Mini B dominates at lower 
concentrations of the two. However, at higher concentration, cholesterol tends to dominate.     
 
3.2 Introduction: 
Lung surfactants [LS] are a complex mixture of lipids and proteins present primarily in the alveolar 
lining of the lungs, produced by Type II epithelial cells [1]. LS help in lowering surface tension at the air-
water interface with expiration, thereby reducing the energy needed for breathing and improving lung 
compliance [2, 3]. They also form a line of defense against any foreign particle that is small enough to 
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make its way through the air canal.[4] It has been firmly established that there is a lack of LS in cases of 
Neonatal Respiratory Distress Syndrome [NRDS] occurring in infants.[5]  On the other hand, a dysfunction/ 
impairment of the surfactant may lead to Acute Respiratory Distress Syndrome (ARDS)/ Acute Lung Injury 
(ALI) and each year, a staggering 50,000- 190,000 cases of ALI/ARDS are reported in USA itself.[6]  Thus, 
the contribution of LS towards a healthy living is vital and the need to understand its composition is 
pivotal.  
The bulk constituent of LS are the phospholipids which amount to around 80% whereas 5-10% are 
the neutral lipids and the rest are the surfactant proteins [7]. The Phospholipids mainly consists of the 
zwitterionic PhosphatidylCholine (PC), which is about 60-70%, whereas, the anionic PhosphatidylGlycerol 
(PG) and PhosphatidylInositol (PI) make up to 8-15%. [8] The saturated DPPC is efficient in lowering the 
values of surface tension to near zero as it forms well packed gel phase [9]. However, the unsaturated 
lipids are needed for adsorption[10] and respreading[11] as they render fluidity to the system. The neutral 
lipids primarily consist of cholesterol[12]. Although less in quantity, the surfactant proteins play a crucial 
part. The hydrophobic SPB and SPC are involved in enhancing adsorption of LS to the air-water interface, 
whereas, the hydrophilic SPA and SPD mainly play a part in immune response [13]. The knowledge of each 
component is essential for Surfactant Replacement Therapy (SRT).  
Till date there is no consensus on the composition of the lung surfactant mixtures available for 
SRT [14]. Two major classes of LS, commercially available for SRT, are: a. animal derived (natural) 
surfactant and b. synthetic surfactant. The natural surfactants are primarily bovine or porcine. So far it 
has been shown that the natural surfactants are better than the synthetic surfactants in terms of 
adsorption, re-spreading, surface tension lowering capacity and film spreading. However, there is a slight 
more risk of intraventricular hemorrhage in case of the natural surfactants [15, 16].  
Amongst the different constituents, cholesterol in SRT is highly disputed and hence, it drew our 
attention. Fig 3.1 shows the structure of cholesterol. It has been shown that cholesterol changes the 
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morphology of DPPC domains even at low concentrations [17]. However, Gunasekara et al., found that 
physiological amount of cholesterol has no effect on the surface activity on a natural surfactant BLES 
(Bovine Lipid Extract Surfactant) and only higher concentration imposes harmful effects on the behavior 
of lung surfactants [18]. Gomez-Gil et al., also showed that cholesterol and natural surfactant protein SP-
C put together in physiological conditions may improve the surface activity of LS. [19] Moreover, Kim  et 
al. recently showed that small amounts of cholesterol lower the surface viscosity of model DPPC 
monolayers, suggesting that addition of small amounts of cholesterol would be beneficial to the efficient 
spreading of synthetic LS in SRT [17] Therefore, in this chapter, we focused on understanding the 
molecular interactions between small and elevated amounts of cholesterol and synthetic surfactant 
protein MiniB in a simple binary phospholipid mixture, DPPC:POPG (7:3), that is often used as a model of 
LS mixtures containing saturated and unsaturated lipids as well as zwitterionic and anionic lipids. We 
particularly focus on the effects of cholesterol on the surface activity and domain morphology of these 
model LS films, in the presence and absence of MiniB.  
 
 
 
 
 
 
 
 
Fig 3.1: Structure of cholesterol (adapted from Avanti Polar Lipids). 
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Mini B is a 34 amino acid residue of the native lung surfactant protein SP-B, where the N and C 
terminals of the native protein are merged together [20, 21]. Fig 3.2 shows the structure of Mini B [20]. 
We are well aware of the functions of SP-B[22].  Removal of SP B gene (SP B-/-) in mice was shown to cause 
fatal post-natal respiratory distress [23] and therefore, SP B is an invaluable component of LS. The 
development of a synthetic analog of SP-B is naturally of therapeutic importance as it overcomes the 
problem of bulk extraction and purification of the native protein. Studies such as that performed by 
Walther et al., showed that MiniB can aid an artificial surfactant, diether phosphonolipid (DEPN), in 
lowering surface tension efficiently [24]. It has also been previously reported that SP-B increases the line 
tension of the phospholipid domains at the air-water interface [25] and thus, Mini B must have similar 
propensity. On the other hand, cholesterol lowers the line tension [17] as can be evidenced by the 
stretching out of the domains. Therefore, Mini B and cholesterol have opposing effects on the lung 
surfactant phospholipids, which is why, we aimed at understanding how the two would behave in the 
same environment.  
 
 
 
 
 
 
 
 
 
Fig 3.2: Structure of Mini B. The disulphide link between the N-terminal and C-terminal is given in yellow. 
This image was adapted from ref. 20.  
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3.3 Materials and Methods: 
3.3.1 Materials: The lipids, 1,2-dipalmitoyl-sn-glycero-3-phosphocholine (DPPC), 1-palmitoyl-2-oleoyl-sn-
glycero-3-phospho-(1'-rac-glycerol) (POPG) and cholesterol were purchased from Avanti Polar Lipids, Inc. 
(Alabaster, AL) in powder form for cholesterol and at final concentrations of either 25 mg/ml or 5 mg/ml 
in organic mixtures of chloroform for the others. The synthetic protein MiniB (a mimic of the native 
surfactant protein SPB) was generously provided by our collaborator, Dr. Alan J. Waring (Department of 
Medicine, Harbor-UCLA Medical Center, Torrance, Ca). Organic solvents, acetone, isopropanol and 
chloroform, were purchased from Thermo Fisher Scientific Inc. (Pittsburgh, PA). The fluorescent dye, 1, 2-
Dihexadecanoyl-sn-Glycero-3-Phosphoethanolamine, Triethylammonium Salt (TXR-DHPE), was obtained 
from Life Technologies (Invitrogen, Grand Island, NY) in a dried form. The lipids were stored at -20 oC to 
prevent any evaporation of the organic mixture. Water which served as a sub-phase as well as cleaning 
agent was purified (resistivity of 18.2 MΩ cm) using Direct-Q 3 UV System purchased from EMD Millipore 
(Billerica, MA).    
3.3.2 Methods: DPPC: POPG solutions were prepared in the ratio of 7:3 by weight as DPPC is the primary 
composition of LS. 1wt%TXR-DHPE  dye was used for imaging purposes. Multiple compositions of MiniB 
and cholesterol along with DPPC and POPG were used which is reported in Table 1.  
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Table 3.1: The table summarizes the LS mixtures tested in this study. Numbers refer to the amount by 
weight of MiniB and cholesterol that was added to a mixture of DPPC: POPG (7:3).  
 
DPPC: POPG (7:3) Cholesterol (wt.) 
 
MiniB (wt.) 
0,0 0,1 0,5 
1,0 1,1 1,5 
5,0 5,1 5,5 
   
 
All the mixtures were diluted in chloroform. Samples were dried down with nitrogen for storage purposes 
in order to retain the activity of the protein.  
A Langmuir trough (Biolin Scientific Inc.), with a moveable ribbon that is  used to mimic the compression 
and expansion process in the alveoli was used such that the a maximum open area of the trough was 166 
cm2, while the minimum area was 46 cm2. Samples were added drop wise with a Hamilton glass Syringe 
on an aqueous sub-phase and 20 minutes were given each time before running the experiment to allow 
the chloroform to evaporate. For isotherm experiments a compression rate of 125 cm2/ min was chosen, 
however, for imaging purposes a slower, quasi-static, rate of 7 cm2/ min was selected to ensure better 
focusing. Surface pressure was measured using Wilhelmy plate balance (filter paper). A Nikon Eclipse 
fluorescence microscope was used to visualize the lipid domain formation on the air-water interface. The 
images, at an interval of 1 to 5 mN/m in the different monolayer phases, were captured using CCD camera 
(Andor LUCA). 5 frames were used for each image sequence and representative imageswere selected for 
reporting purposes.  
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The domain morphology and size of the liquid condensed domains  were analyzed with ImageJ (NIH) 
software. Two neighboring images were analyzed for each image sequence for better statistical quality. 
Graphs were generated using Origin 8.62 (OriginLab, Northampton, MA).  
 
3.4 Theory: 
3.4.1 Compressibility modulus: The compressibility of an interface is used to understand the mechanical 
properties of a monolayer. The two-dimensional isothermal bulk-modulus, β, calculated to understand a 
substance’s ability to store energy in the form of stress, is given by the following equation:  
                                                           
                                                                                                                                                                  
 
(1) 
Here, κ is the isothermal compressibility. 
β, as well κ, are the second order derivative of Gibb’s free free energy and any dip in the β vs. A curve 
implies a first order phase transition. From a compressibility modulus data we can comment on the 
packing of a monolayer and higher incompressibility is essential for the proper functionality of LS.  
 3.4.2 Condensed Area Fraction: The condensed area fraction is the ratio of the total condensed area, i.e., 
the dark domains found in the two-phase coexistence region and beyond, to the total area of the image. 
It provides us with an estimate of the fraction of the monolayer that has condensed at a given surface 
surface pressure. Mathematically, the percentage area fraction is: 
 
 
 
(2) 
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3.4.3 Determining line tension from domain size distribution: The shape of lipid domains in a monolayer 
depends on a balance between the electrostatic energy and  the line tension. Based on this theory along 
with the minimization of free energy, the size distribution of the domains can be given by the following 
equation[25].  
 
 
 
(3) 
Here, CN and CM are the fraction of domains. Δm is the dipole density, Ro is the radius corresponding to 
minimum energy, ε is the dielectric constant for interfacial water, εo is the permittivity of vacuum, kB is the 
Boltzmann constant and T is the temperature. The parameters, CM, (Δm)2Ro/ 4εεokBT and Ro are evaluated 
using a non-linear curve fit and then, the following equation [25], relating Ro with line tension (λ) and Δm, 
is used to determine the line tension of the lipid domains. 
    
 
(4) 
3.5 Results: 
3.5.1 Isotherms: Figure 3.3 presents the quasi-static surface pressure vs mean molecular area isotherms 
of the different samples examined. Each sample was tested thrice and the plots given here are the 
representative ones. Here, surface pressure is the difference between the surface tension of pure water 
and the surface tension of water containing surfactants. Mathematically,  
    Surface Pressure, Π= (γ0 – γ)  
(5) 
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Where γ0 is the surface tension of pure water (72 mN/m) and γ is the surface tension of water with 
surfactant. As the area of the trough is reduced, surface tension of Langmuir  monolayers decrease due 
to increased packing  or the surface pressure of the Langmuir film increases .  
Fig 3.3A shows how the isotherm of a mixture of DPPC:POPG was modified by varying the concentration 
of Mini B. The solid line represents the control curve for DPPC:POPG. At higher mean molecular areas, the 
monolayer was in a gaseous phase. However, with the decrease in area, the monolayer went through 
changes in phase and the molecules got more ordered. In case of the control, the coexistence of the liquid-
expanded phase and the liquid-ordered phase was approximately between the surface pressure 15 mN/m 
and 30 mN/m. Beyond this point, there was a rapid rise in surface pressure with very little area 
compression and the monolayer finally collapsed at close to 72 mN/m. With the addition of 1 % Mini B to 
the system, we observed practically no change in the isotherm. This curve is given as dashed line and it 
almost overlaps with that of the control. However, when 5 % Mini B was added to DPPC:POPG, given by 
the dotted line, the isotherm got shifted to higher values of surface pressure at any given mean molecular 
area. This suggests that with the inclusion of higher amount of Mini B, there is an ease in the lowering of 
surface tension.   
Fig 3.3B represents the effect of addition of varying amounts of cholesterol on the isotherm of 
DPPC:POPG. With the addition of 1% cholesterol, given by dash dot curve, there was no significant change 
in the isotherm. However, there was a shift of the isotherm to lower values of mean molecular area at the 
higher pressures corresponding to collapse region. With the addition of 5% cholesterol to DPPC:POPG, 
isotherm deviated even further towards the lower area values suggesting greater changes in the 
mechanical properties at the collapse. Other than that, the slope of the liquid-condensed region was 
shifted to slightly higher mean molecular areas.  
Fig 3.3C is a plot of DPPC:POPG mixed with 1 % MiniB and varying composition of cholesterol. This plot 
shows how 1% of the artificial surfactant protein interacts with multiple concentrations of cholesterol. 
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The isotherm for MiniB 1 % and cholesterol 1 % is shown by the dashed curve. Here, we could observe 
that the isotherm was pushed to higher values of surface pressure for the same mean molecular area. 
This again suggests an improvement in the surface tension lowering capabilities of the surfactant. Next, 
the concentration of cholesterol was raised to 5 % and the curve (dotted lines) fell back close to the 
control.    
Fig 3.3D represents the effect of 5 % Mini B with cholesterol on DPPC:POPG. 1 % cholesterol, given by 
dashed line, overlapped with the control till the two phase coexistence region of the isotherm. Beyond 
this, the slope for the condensed region was lower than that of the control. This indicates that this mixture 
is not as efficient as the control in lowering surface tension. The effect was more pronounced with 5 % 
Mini B and 5 % cholesterol as can be seen from the thin dashed curve. The isotherm moved further to the 
left of the control indicating the need for higher area compression to achieve the same values of surface 
pressure.  
3.5.2 Compressibility Modulus: Fig 3.4 presents the compressibility modulus as a function of mean 
molecular area of the samples tested. The data was processed using an FFT filter over 5 points.  
Fig 3.4A shows the compressibility modulus for varying composition of Mini B with DPPC:POPG. In case of 
the control, the compressibility modulus gradually increased till it reached around 30 mN/m and after 
this, there was a slight dip in the curve. At around 45 mN/m there was again a rise in the compressibility 
modulus with the peak touching a value of 70 mN/m, beyond which, there was a sharp fall. In case of 1 % 
Mini B, presented as dashed lines, there was almost no change, till a slight decrease in the values for the 
second peak was observed. 5 % Mini B on DPPC:POPG was more compressible at lower mean molecular 
areas. But, it almost overlapped with the control when the mean molecular area was reduced to 
approximately 45 mN/m. The second peak in this case was lower than control suggesting reduced 
compressibility i.e., less packing.  
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Fig 3.4B shows the effect of different concentration of cholesterol on the compressibility modulus of 
DPPC:POPG. With 1 % cholesterol, there was a lowering of the compressibility of the system at low mean 
molecular area. There was a slight shift of the peak towards higher area. However, with 5 % cholesterol, 
there was appreciable change in the compressibility data at areas lower than 60 Å2/ molecule. The 
maximum compressibility dropped and moved even further towards lower areas.  
Fig 3.4C gives the compressibility modulus for systems containing both Mini B and cholesterol. With Mini 
B 1 % and cholesterol 1 % (dashed curve), there was an increase in the compressibility of the system. This 
suggested a change in the domain morphology at the air-water interface. In case of 1 % Mini B and 5 % 
cholesterol (dotted line), the curve shifted to the left and the peak was nearly the same as that for the 
control.  
Fig 3.4D represents the compressibility modulus of DPPC:POPG along with 5 % Mini B and varying 
concentration of cholesterol. Here, we found appreciable deviation from the control. The slope at area 
lower than 50 Å2/ molecule was more gradual than the control and at higher compression, the value of 
the peak was lower. The same changes were even more prominent for Mini B 5 % and cholesterol 5 %.  
3.5.3 Flourescence Images: To have a better understanding of the changes occurring at the monolayer, 
we performed fluorescence microscopy to monitor changes in the monolayer domain morphology and 
size. Images were recorded throughout the monolayer compression cycle at intervals of 5 mN/m. 
However, we present here images at surface pressures 20 mN/m, 30 mN/m (Fig 3.5)  and at monolayer 
collapse (Fig 3.6) for simplicity. At 20 mN/m, the monolayer has two phases, namely the liquid expanded 
(LE) and the liquid condensed (LC) phases, coexisting simultaneously for DPPC:POPG and 30 mN/m marks 
the upper boundary for this phase-coexistence region. Beyond thissurface pressure, the samples get 
densely packed. At the highest values of surface pressure, (coinciding with lowest values of surface 
tension) we visualize cracks and “folds” on the surface of the monolayer. These features mark the 
60 
 
transition of material from a two-diensional film to the three-dimensional bulk phase. Such features 
appear in the monolayer since material is squeezed out of the monolayer due to excessive compression.   
 
3.5.3.1 Phospholipid monolayer domain morphology: Fig 3.5A and 3.5D shows the images for 
DPPC:POPG (7:3) at surface pressures 20mN/m and 30 mN/m respectively. Contrast in these images is 
due to the selective segregation of the dye molecules. The dark regions are the condensed domains where 
the bulky dye molecules cannot insert themselves, whereas the lighter region is in liquid-expanded phase 
allowing the dye to blend in. In case of the control, the monolayer was found to be well packed beyond a 
surface pressure of 20 mN/m, agreeing with  previously reported results [26]. The domains were more or 
less circular in shape. Fig 3.5B and Fig 3.5E shows the images for DPPC:POPG (7:3) with 1 wt. % cholesterol 
added to the system. Here we observed a drastic change in the domain morphology. The domains 
stretched out and in place of the circular condensed regions, we found protruding spirals along the 
boundaries. The effect became more pronounced with the rise in the surface pressure. Fig 3.5C and 3.5F 
shows the effect of adding 5 % cholesterol to a DPPC:POPG mixed lipid system. In this case,  the domains 
were even more stretched out. Moreover, the packing density of liquid condensed domains decreased 
significantly. Next, we monitored the effect of 1% Mini B on DPPC:POPG (Fig 3.5G and 3.5J). The shapes 
were similar to the control as can be seen in the images. Fig 3.5H and 3.5K had 1 % Mini B and 1 % 
cholesterol in the system. Here, the edges did not modify. Although, the domains were no longer round 
in shape, yet, Mini B did not allow cholesterol to completely dominate the domain formation. The domains 
got curled up in this case. With 1 % Mini B and 5 % cholesterol (Fig 3.5I and Fig 3.5L) the domains were 
completely transformed without getting packed at all. Images 3.5M and 3.5P show the effect of 5 % Mini 
B. Here, the domains appeared less packed and smaller in size. However, the shape remained the same. 
Fig 3.5N and Fig 3.5Q shows the effect of 1 % cholesterol along with 5 % Mini B. There were no appreciable 
changes in the shape of the domains and Mini B dominated over the presence of cholesterol. Finally, we 
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monitored phospholipid films containing   5 % Mini B with the same concentration of cholesterol added 
to DPPC:POPG. In these monolayers,the size of the domains was found to be smaller. However, 
cholesterol could not modify the shape of the domains. The monolayer was much less packed.  
  
3.5.3.2 Collapse: When LS monolayer is compressed, the unsaturated lipids, which cannot sustain high 
pressure, squeezes out of the monolayer. Thus, a transition from 2D monolayer to a 3D multilayer occurs. 
This is termed as the collapse and Fig 3.6 shows the images that were taken after the surfactant films had 
collapsed. Such a collapse is due to buckling of the film rather than fracture or solubilization. In case of 
fracture or solubilization, there is a loss in the material from the surface as these squeezed out materials 
cannot be reincorporated into the monolayer with subsequent compression expansion cycles [27]. Thus, 
in those cases, the materials collapse irreversibly, and appear as bright dots on the air-water surface. Large 
bright fold-like regions on the monolayer are indicative of reversible collapse with lower loss of material. 
These bright regions resembling cracks on the surface can be compared to that formed by folding a piece 
of paper and can be visualized in Fig 3.6A in case of the DPPC:POPG controlled system.  When cholesterol 
is incorporated into the system (Fig 3.6B for 1 %and 3.6C for 5 %), this crack across the monolayer, 
disappears and instead bright dots, begin to appear at the surface. This suggests that cholesterol hinders 
the retention of lung surfactant material near the surface. On the contrary, when MiniB is added to the 
system, there is an increase in the collapse crack, both for 1 % and for 5 %. Fig 3.6D and 3.6G shows the 
formation of thick collapse cracks in case of 1 % and 5 % respectively. Fig 3.6E shows the effect of 1 % 
cholesterol and 1 % Mini B on DPPC:POPG. The lines still form in this case indicating that even higher 
surface pressures, Mini B does not allow cholesterol to completely dominate over the behavior of the 
system. However, with 5 % cholesterol and 1 % MiniB (Fig 3.6F), there was hardly any bright region on the 
surface. Fig 3.6H shows the effect of 1 % cholesterol and 5 % Mini B. Here we can again find substantial 
amount of crack on the surface, indicating the dominance of higher weightage of Mini B over cholesterol. 
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Finally, 5 % of both the components showed a large number of dots on the surface. The cracks appeared 
similar to the ones formed by folding cardboard instead of a paper.    
 
3.5.4 Percentage Condensed Region: Fig 3.7 shows the percentage of the monolayer that formed Liquid-
Condensed region. The amount of condensed region may contribute to the fluidity of the monolayer. 
Surface pressures 15, 20, 25 and 30 mN/m were chosen as they represent the two phase region. Fig 3.7A 
shows the effect of cholesterol on DPPC:POPG. The condensed domain increased from 50% to 60% as a 
function of SP in case of the control system. However, with cholesterol, there was a reduction in the total 
area of condensed domains. The effect was more pronounced in monolayer films containing higher 
concentrations of cholesterol. Fig 3.7B shows how Mini B alters the formation of condensed domains in 
DPPC:POPG. With 1% Mini B, there was lowering in the domains till 20 mN/m surface pressure, however, 
at 25 and 30 mN/m, there was an increase. But with 5% Mini B there was a drop in the condensed domains 
throughout. The next two figures reveal how Mini B and cholesterol both act together in altering the area 
of the dark domains. In Fig 3.7C the composition of Mini B was fixed at 1% and cholesterol was varied. 
Here again, with 1% of both put together there was increase in the domain area at 25 and 30 mN/m. but, 
5% cholesterol dominated over 1% Mini B. There was a significant drop in the condensed domain in this 
case. Fig 3.7D shows the effect of varying amount of cholesterol on 5% Mini B. In this case, 5% Mini B 
dominated over cholesterol, however at equal concentration of the two components, the area reduced 
drastically. This showed the dominance of higher concentration of cholesterol even with equal amount of 
Mini B. 
3.5.5 Line Tension: The model to calculate the line tension used here is only feasible for lipid domains that 
are circular in shape. So we were limited to measuring line tension of the domains for the control, lipid 
mixture with both 1% and 5% Mini B and the mixtures that had 5% Mini B and varying concentration of 
cholesterol. Surface pressures 15 mN/m and 20 mN/m were selected for the ease of analysis. Beyond this 
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pressure, the monolayer gets relatively more packed, making it hard to analyze. The line tension of the 
control (Fig 3.8A) was around 3 x 10-2 pN at 15 mN/m and this value dropped to 2.4 x 10-2 pN. However, 
with the addition of MiniB, there was a rise in the line tension. Also, in this case, there was an increase in 
line tension with surface pressure. With 1% Mini B, line tension was around 4.5 x 10-2 pN at 15 mN/m and 
5 x 10-2 pN at 20 mN/m. 5% Mini B showed values slightly higher than those for 1%. When 1% cholesterol 
was added to 5% Mini B (Fig 3.8B), there was a rise even though cholesterol on its own is known to reduce 
line tension. However, when 5% cholesterol was added instead of 1%, there was a drop in line tension 
revealing the dominance of cholesterol over Mini B in this case.  
 
3.6 Discussion: 
This work is inspired by the viability of Mini B to act as a surfactant protein in SRT. Also, cholesterol is a 
highly debated component of the LS and majority of the LS mixtures in SRT avoid cholesterol. Previous 
work has shown the harmful effects of cholesterol on LS mixtures [28, 29]. However, we wanted to 
observe whether Mini B can play a role in countering the effects of cholesterol on LS. We used a simple 
LS mixture, DPPC:POPG mixed in the weight ratio of 7:3, to understand the above interaction. This ratio 
was selected because DPPC forms the main component of LS, whereas POPG is representative of the 
anionic lipids found in LS, and this composition is used as a standard mixture in biophysical studies related 
to this area of research. We obtained surface pressure-mean molecular area isotherms to determine 
whether these two components alter the capability of the lipid mixture to lower surface tension, which is 
the primary function of LS. From this, we also looked into the changes in the mechanical properties of the 
system by deriving the compressibility modulus. Finally, we scrutinized them under the microscope to 
visualize the changes in the phospholipid domain formation in the presence of Mini B and cholesterol, 
both individually as well as put together. Our results show that lower amount of Mini B as well as 
cholesterol (1 %) enhances the properties of LS. However, high concentration of Mini B and cholesterol (5 
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%) put together plays a negative role. The domains, as seen previously [30], changes drastically in the 
presence of cholesterol and the effect is, to a certain extent, countered by Mini B. We will discuss the 
results in more details in the following sub-sections. 
3.6.1 Effect on Mechanical Properties: The surfactant mixture DPPC:POPG is efficient in lowering surface 
tension to near zero values owing to the presence of the disaturated phospholipid which has been 
reported previously[31]. A low concentration of Mini B does not alter this property at all. However higher 
concentration introduced an early condensation in the lipid mixture at the air-water interface. On the 
other hand, we found changes only in the collapse pressures in case of cholesterol while at lower 
pressures there was practically no change in the surface tension lowering abilities with the concentrations 
tested. Next, we tried a combination of both the components and we noted appreciable changes in this 
case. A lower concentration of both the components showed an improvement. However, equal amounts 
of both at higher concentration had detrimental effects on the LS. The surface tension in this case fell 
short of the zero mark. Even when the concentration of Mini B was higher than that of cholesterol, LS 
failed to put up a good performance. This suggests that beyond a certain concentration of the two put 
together, there is an adverse effect.  
 Compressibility modulus of the system can be derived directly from the pressure vs. area 
curve[32]. The compressibility of the system lowers in the presence of cholesterol, however, Mini B does 
not have an appreciable effect on the fluidity of the system. When the two are put together in equal but 
low concentration, there is an increase in the compressibility of the system. A higher concentration of the 
two, on the other hand, showed significant fluidization in the system which proved to be unfavorable for 
achieving low surface tension.  
 From the above data we concluded that a low concentration of both Mini B and cholesterol may 
aid LS in carrying out its desired function. We then looked into the lipid domains in more details to have 
a better understanding of the system.  
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3.6.2 Tug of war: Effect on Lipid Domain Formation: DPPC:POPG forms almost circular domains at the 
air-water interface[26]. By 20 mN/m surface pressure, the domains get very well packed owing to the 
presence of high percentage of DPPC. At surface pressures close to 70 mN/m, DPPC:POPG collapses 
reversibly. This was apparent because of the presence of the bright folded region in the monolayer. At 
lower surface pressures, Mini B reduces the packing density of the domains. However, it causes no change 
in the domain structure of DPPC:POPG. At higher surface pressures giant folds are formed which suggests 
Mini B, like SP B [33], helps in holding the surfactants near the surface. Therefore, Mini B allows the 
subsequent cycles of compression and expansion to reutilize the unsaturated lipids, preventing loss due 
to squeeze-out. Cholesterol, on the other hand, shows a very opposing effect on DPPC:POPG. The domains 
stretch out and the effect becomes more pronounced as the concentration of cholesterol is increased. It 
significantly lowers the packing as well. Although the changes were subtle in case of the isotherms, as we 
took a closer look, the film was much more fluid in presence of cholesterol. At higher surface pressure 
cholesterol prevents the formation of collapse cracks. Instead, solubilization occurs and materials get lost 
to the subphase. However, there is a tug of war when Mini B and cholesterol are both present together. 
Mini B tries to keep the domains circular whereas cholesterol wants to stretch it apart. At uneven 
concentration, either Mini B or cholesterol dominates depending on which one has the higher weight. 
This is true at both lower end as well as the upper end of the surface pressure-area isotherm. However,1% 
of both the components put together, reveals that even though cholesterol tries to stretch out the 
domains to lower line tension, the change is not as drastic as that can be seen only in case of cholesterol. 
There was an increase in the area of the condensed domain at higher pressures as can be seen in Fig 3.7C.  
The presence of cholesterol did not adversely affect the mechanisms of reversible collapse. When 5% of 
both Mini B and cholesterol were added to the system, there was no change in the shape of the domain 
but the domains size was reduced. Fig 3.7D clearly shows the decrease in the percentage condensed 
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domain when higher concentration of both was used. Here again, at collapse, solubilization of the material 
was more predominant.  
Therefore, the images show a balance of the substances at lower concentration and a lower 
concentration of the two components put together is favorable. 
 
3.6.3 Effect on Line Tension: Line tension between the domains contributes to the viscoelasticity of the 
monolayer at the air-water interface. This viscoelasticity controls the spreading and rate of collapse of the 
monolayers [25]. More viscous properties are needed for the material to spread uniformly along the entire 
surface, however, the monolayers should be elastic enough to fold under high compression and get 
readsorbed quickly to the interface with subsequent expansion. Cholesterol reduces the line tension of 
the phospholipid domains, which causes lipids to stretch out. However, Mini B helps in increasing the line 
tension of the domains. Fig 3.8A revealed this rise in line tension with the addition of Mini B. The model 
we used is applicable only for circular domains. Therefore, when cholesterol and Mini B both were added 
to the system, only the data for 5% Mini B and varying concentration of cholesterol could be analyzed. At 
both 15 mN/m and 20 mN/m, there was an increase in the line tension when the composition of 
cholesterol was lower than that of Mini B. However, with 5% of both the components, there was a 
decrease in the line tension value.  
 Therefore, both percentage condensed domain and line tension analysis revealed the 
disadvantage of using cholesterol and Mini B together at higher concentration. However, a smaller 
amount of the two can definitely benefit LS. 
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3.7 Conclusion:  
The research reported here puts forward the opposing effects of the synthetic LS protein Mini B and the 
much debated cholesterol at the air-water interface on the quasi-equilibrium state of the phospholipid 
domain morphology. We observed that Mini B alone serves the important purpose of keeping much of 
the LS components from being lost into the sub-phase as the monolayer is compressed. It also increases 
the line tension of the domains, which in turn maintains the stability of the domains. Cholesterol, on the 
other hand, increases the fluidity of the lipid but drastically transforms their shapes as well as makes the 
lipids collapse irreversibly. A high concentration of cholesterol, as already mentioned in the literature, is 
not advisable and may even result in ARDS. However, the two components together even out the 
opposing forces, and a competitive synthetic composition of LS for SRT is possible. From our studies we 
conclude that low concentration of cholesterol and Mini B together can help in achieving the desired high 
surface pressure while keeping the film adequately fluid along with collapsing reversibly with thick cracks. 
The inclusion of Mini B into the system can be advantageous as it is purely synthetic and therefore the 
yield will be much higher than using the natural counterpart. Addition of cholesterol is needed as it makes 
the lipid mixture more dynamic and it is a part of the natural surfactant. Our report therefore, provides 
the evidence that it is possible to include both Mini B and cholesterol.      
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3.8 Figures: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.3: Surface pressure vs. mean molecular area isotherms for different lung surfactant mixtures. (A) 
DPPC:POPG (7:3) with 1% and 5% MiniB. (B) DPPC:POPG with 1% and 5% cholesterol. (C) DPPC:POPG 
with 1% MiniB and varying concentration of cholesterol (D) DPPC:POPG with 5% MiniB and different 
weightage of cholesterol. The isotherms indicate an improvement in surface tension lowering abilities 
with 1% of both Mini B and cholesterol in the mixture.  
(A) 
(D) (C) 
(B) 
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Fig 3.4: Compressibility Modulus for different lung surfactant mixtures. (A) DPPC:POPG (7:3) with 1% 
and 5% MiniB. (B) DPPC:POPG with 1% and 5% cholesterol. (C) DPPC:POPG with fixed MiniB percentage 
(1%) and varying weightage of cholesterol (D) DPPC:POPG with 5% MiniB and different amounts of 
cholesterol. Higher concentration of MiniB and cholesterol makes the monolayer more compressible 
whereas lower concentration of the increases the compressibility. An increase in compressibility modulus 
implies more packing and is therefore, favorable.  
 
 
 
(A) 
(C) (D) 
(B) 
(A) (B) (C) 
(A) 
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Fig 3.5: Fluorescence images of DPPC:POPG (7:3) along with MiniB and cholesterol in varying 
concentrations. Images A, B, C, G, H, I, M, N, O, P, Q and R were taken at 20 mN/m which lies in the two-
phase coexistence region and the rest were taken at 30 mN/m which marks the upper boundary for the 
same region. Beyond this point, the domains get highly packed for the control. The first two rows are for 
samples without MiniB, the next couple rows are for samples with 1% MiniB in them, and the last two are 
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for ones with 5% MiniB. Concentration of cholesterol increases from left to right. The images reveal the 
inherent tendency of cholesterol to stretch out domains whereas, the MiniB showed opposite 
characteristics.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 3.6: Fluoresecence images of DPPC:POPG(7:3) with different concentrations of MiniB and cholesterol 
after collapse. Concentration of MiniB changes columnwise whereas, the concentration of cholesterol 
changes along a row. MiniB produces thick cracks (D and G) upon collapse but cholesterol collapses 
irreversibly (B and C). With both put together, cracks can still be observed in case of 1% MiniB with 1% 
cholesterol (E) or 5% MiniB with 1% cholesterol (H). However, cholesterol dominates at higher 
concentration (F and I). DPPC:POPG on its own produces thin collapse cracks (A). 
MiniB 0% 
MiniB 1% 
MiniB 5% 
Chol 0% Chol 1% Chol 5% 
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Fig 3.7: Percentage condensed domains for varying mixtures of DPPC:POPG (7:3). Percentage condensed 
domains show the amount of area that has condensed in the two-phase coexistence region. (A) Effect of 
MiniB on DPPC:POPG has been shown here. A reduction in the area was noted for 5% MiniB. (B) 
cholesterol reduces the area and the effect is more pronounced with an increase in choleserol 
concentration. (C) Interaction of 1% MiniB with different concentrations of cholesterol has been shown in 
this graph. Interestingly, 1% MiniB along with 1% cholesterol (inverted triangle) increases the area of the 
condensed domains. (D) 5% MiniB along with different concentrations of cholesterol showed a decrease 
in area everytime.   
73 
 
 
 
 
 
Fig 3.8: Changes in line tension for different mixtures. (A) MiniB increases the line tension between the  
domains (B) We could only measure the line tension for 5% MiniB with 1% cholesterol and 5% MiniB with  
5% cholesterol as these domains were circular in shape. 1% MiniB with 1% cholesterol did not lower the 
line tension whereas, 5% of both revealed a lowering in line tension.  
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Summary 
The first chapter deals with the interaction of LS with anionic Engineered Carbon Nanodiamonds [ECN], a 
carbon based nanoparticle capable of serving as a carrier for drug delivery by inhalation. To assess the 
bio-toxicity of any nanoparticle, research so far has focused on changing the characteristics of those 
particles without stressing on the importance of the lipid mixture under concern. However, based on 
Surface pressure-area isotherms and Fluorescence Microscopy at an air-water interface, along with 
Atomic Force Microscopy, we reveal that this interaction is also modulated by the lipid head-group charge 
and alkyl chain saturation. Our study shows that ECN alters the shape of the phospholipid domains in the 
presence of zwitterionic lipids, but, in case of lipid mixtures containing anionic lipids, the negatively 
charged ECN lowers the packing density without modifying the shape of the domains.   
 The subsequent chapter focuses on understanding the interaction between MiniB, a synthetic 
analog of the natural surfactant protein SPB, and cholesterol, whose purpose and use is highly debated in 
SRT, in the presence of a simple binary mixture of LS phospholipids, namely, 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) and 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (POPG). This 
study was undertaken as there is yet to be a consensus on the composition of LS used in SRT, especially 
the interaction between the various components of the mixture. Based on surface pressure-area 
isotherms and fluorescence imaging under constant compression, we conclude that a low concentration 
of Mini B along with an equal concentration of cholesterol aids in the proper functioning of synthetic LS. 
cholesterol prefers to stretch out the phospholipid domains by lowering line tension and also makes LS 
collapse irreversibly. On the contrary, a domain size distribution analysis reveals that Mini B increases line 
tension between the domains. Mini B also helps LS to collapse reversibly forming giant folds, therefore, 
preventing material loss from the interface. A tug of war ensues as the two are put together and Mini B 
dominates at lower concentrations of the two. However, at higher concentration, cholesterol tends to be 
the dominating component.      
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Conclusion and Future Directions 
The study involving the interaction of Engineered Carbon Nanodiamonds [ECN] with different lipid 
systems, has proven the importance of lipid headgroup charge and alkyl chain saturation in assessing 
nanotoxicity. We have come to the conclusion that the effect of the nanoparticles will depend on where 
they are administered and what lipid environment they are exposed to. However, we looked only into 
ECN which are negatively charged and spherical in shape. Future studies would need to focus on using 
nanoparticles with different aspect ratios, size and possibly other physicochemical properties while also 
varying the lipid composition to obtain a complete biophysical understanding of lipid/nanoparticle 
interactions in varying lipid environments. Additionally, future studies in our group will also focus on the 
effect of ionic strength and the presence of ions with different valence on nanoparticle induced changes 
in lipid domain packing. A complete understanding of the fundamental physical principles governing lipid-
nanoparticle interactions are essential in order to develop methods to predict the potential adverse 
effects of ENPs with varied applications.   
We also observed the interaction between cholesterol and MiniB which is very specific to lung 
surfactant research and Surfactant Replacement Therapy. Our data revealed the potency of the synthetic 
protein MiniB to counter the harmful effects of cholesterol.  
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